Table 2.

Kaplan-Meier survival analysis for overall (OS), disease-free (DFS) and local-recurrence free (LRF) survival relative to gene expressions (n): number of patients

	OS means (months)	95% CI (months)	OS (5 years)%	p-value
TRF2 (n)
High expression (13)	73.0	58.1 – 87.8	69.2	0.154
Low expression (7)	49.9	27.9 – 71.9	28.6
Bcl-xL (n)
High expression (11)	46.5	30.4-62.7	27.3	0.002*
Low expression (9)	86.8	77.7-95.9	88.9
p53 (n)
High expression (9)	48.6	29.3-67.9	33.3	0.02*
Low expression (11)	78.1	64.2-91.9	72.7
	DFS means (months)	95% CI (months)	DFS (5 years)%	p-value
TRF2 (n)
High expression (13)	70.3	53.3 – 87.3	69.2	0.124
Low expression (7)	43.9	21.1 – 66.8	28.6
Bcl-xL (n)
High expression (11)	41.1	23.9-58.4	27.3	0.003*
Low expression (9)	84.8	72.0-97.5	88.9
p53 (n)
High expression (9)	45.8	25.7-66	33.3	0.04*
Low expression (11)	73.4	55.4-91.2	72.7
	Local control means (months)	95% CI (months)	LRF (5 years)%	p-value
TRF2 (n)
High expression (13)	58.7	44.4-72.9	76.9	0.750
Low expression (7)	54.5	32.2-76.9	57.1
Bcl-xL (n)
High expression (11)	45.4	26.4-64.3	45.5	0.01*
Low expression (9)	71.6	66.0-77.0	88.9
p53 (n)
High expression (9)	49.5	28.4-70.7	55.6	0.10
Low expression (11)	43.4	30.7-76	72.7

*Correlation is significant at the 0.05 level (2-tailed).